Pretax income is the income that a company earns before paying income taxes. Organovo Holdings's pretax income for the
three
months ended in Mar. 2024 was €-2.80 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was €-13.56 Mil.
Organovo Holdings's pretax margin was -10,374.07%.
During the past 13 years, Organovo Holdings's highest Pretax Margin was -756.05%. The lowest was -13457.80%. And the median was -908.37%.
Organovo Holdings Pre-Tax Income Historical Data
The historical data trend for Organovo Holdings's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Organovo Holdings's Pre-Tax Income
For the Biotechnology subindustry, Organovo Holdings's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Organovo Holdings's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Organovo Holdings's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Organovo Holdings's Pre-Tax Income falls into.
Organovo Holdings Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Organovo Holdings's Pretax Income for the fiscal year that ended in Mar. 2024 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-13.56 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Organovo Holdings (STU:4OR1) Pre-Tax Income Explanation
Organovo Holdings's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as
During the past 13 years, Organovo Holdings's highest Pretax Margin was -756.05%. The lowest was -13457.80%. And the median was -908.37%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Organovo Holdings Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Organovo Holdings's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:4OR1 has been successfully added to your 